PA
GMAB icon

Pinnacle Associates’s Genmab GMAB Stock Holding History

Pinnacle Associates’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-31,541
Closed -$1.28M – 746
2020
Q4 		$1.28M Sell
31,541
-50
-0.2% -$1.87K 0.03% 365
2020
Q3 		$1.16M Hold
31,591
– – 0.03% 349
2020
Q2 		$1.07M Buy
31,591
+285
+0.9% +$7.77K 0.03% 348
2020
Q1 		$663K Sell
31,306
-460
-1% -$10.3K 0.02% 409
2019
Q4 		$709K Hold
31,766
– – 0.02% 479
2019
Q3 		$644K Buy
+31,766
New +$626K 0.02% 489

Other funds holding GMAB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
1832 Asset Management
1832 Asset Management Toronto, Ontario, Canada $109B AUM 35.56% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

Pinnacle Associates's GMAB Position: Q1 2021 in Review

Pinnacle Associates sold out of Genmab (GMAB) in Q1 2021, closing a stake of 31,541 shares — an estimated $1.28M sold.

Pinnacle Associates first reported a position in GMAB in Q3 2019 and held it in 6 quarters. The position peaked at $1.28M in Q4 2020. 209 funds tracked by Wall St. Rank hold GMAB as of Q1 2021.

  • Pinnacle Associates reported no remaining Genmab position as of Q1 2021 after selling out during the quarter.
  • Pinnacle Associates sold 31,541 Genmab shares in Q1 2021, an estimated $1.28M.
  • Pinnacle Associates first reported a position in Genmab in Q3 2019 and held it in 6 quarters.
  • Pinnacle Associates's Genmab position peaked at $1.28M in Q4 2020.
  • 209 funds tracked by Wall St. Rank held Genmab as of Q1 2021.

Based on Pinnacle Associates's 13F filing for Q1 2021, filed 12 May 2021.